Product Description: Radezolid (RX-1741) is a oxazolidinone antibiotic. Radezolid is active against Staphylococcus, Chlamydia, and Legionella species, and remains active against Linezolid-resistant strains[1][2].
Applications: COVID-19-immunoregulation
Formula: C22H23FN6O3
References: [1]Lemaire S, et al. Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila./[2]Locke JB, et al. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.
Antimicrob Agents Chemother. 2010 Dec;54(12):5337-43.
CAS Number: 869884-78-6
Molecular Weight: 438.45
Compound Purity: 99.27
Research Area: Infection
Solubility: DMSO : ≥ 25 mg/mL
Target: Antibiotic;Bacterial
Deutsch
English
